Long-term effects of nonimmune tissue injury in renal transplantation

Current Opinion in Organ Transplantation

Volumn 7, Issue 2, 2002, Pages 171-177

  Melk, Anette ^a   Gourishankar, Sita ^a   Halloran, Philip F ^a  

^a UNIVERSITY OF ALBERTA   (Canada)

Author keywords

[No Author keywords available]

Indexed keywords

ANTIHYPERTENSIVE AGENT; CALCINEURIN INHIBITOR; CYCLOSPORIN; HLA ANTIGEN; RAPAMYCIN;

ARTICLE; AUTOIMMUNE DISEASE; BRAIN DEATH; DISEASE ASSOCIATION; DISEASE COURSE; DRUG TOXICITY; HUMAN; HYPERTENSION; KIDNEY ALLOGRAFT REJECTION; KIDNEY BLOOD VESSEL; KIDNEY FIBROSIS; KIDNEY TRANSPLANTATION; NEPHROTOXICITY; NONHUMAN; ORGAN PRESERVATION; PATHOPHYSIOLOGY; RAT; TISSUE INJURY; TISSUE REPAIR;

EID: 0036060677     PISSN: 10872418     EISSN: None     Source Type: Journal    
DOI: 10.1097/00075200-200206000-00011     Document Type: Article

References (77)

1. The UNOS scientific renal transplant registry
2. Rethinking chronic allograft nephropathy: The concept of accelerated senescence
3. Cell senescence and its implications for nephrology
4. Inhibition of experimental liver cirrhosis in mice by telomerase gene delivery
5. Delayed graft function: State of the art, November 10-11, 2000: Summit meeting, Scottsdale, Arizona, USA
6. Impact of delayed graft function and acute rejection on kidney graft survival
7. The Banff 97 working classification of renal allograft pathology
8. Histopathology of chronic renal allograft dysfunction
9. Fibrous intimal thickening at implantation as a risk factor for the outcome of cadaveric renal allografts
10. The importance of donor vascular pathology in determining renal allograft outcome
11. Protocol renal allograft biopsies and the design of clinical trials aimed to prevent or treat chronic allograft nephropathy
12. Serial protocol biopsies to quantify the progression of chronic transplant nephropathy in stable renal allografts
13. Effect of histological damage on long-term kidney transplant outcome
14. Impact analysis: A method for evaluating the impact of factors in clinical renal transplantation
15. The influence of donor age on kidney graft survival in the 1990s
16. Significance of the donor age effect on kidney transplants
17. The UNOS scientific renal transplant registry: 2000
18. Time-dependent risk factors influencing the long-term outcome in living renal allografts: Donor age is a crucial risk factor for long-term graft survival more than 5 years after transplantation
19. Factors in older cadaveric organ donors impacting on renal allograft outcome
20. Risk factors for renal allograft survival from pediatric cadaver donors: An analysis of united network for organ sharing data
21. The combined impact of donor age and acute rejection on long-term cadaver renal allograft survival
22. Increased immunogenicity and cause of graft loss of old donor kidneys
23. Determinants of long term survival of adult kidney transplants
24. Impact of pre-existing donor hypertension and diabetes mellitus on cadaveric renal transplant outcomes
25. Evaluation of the older cadaveric kidney donor: The impact of donor hypertension and creatinine clearance on graft performance and survival
26. The influence of donor brain death on short and long-term outcome of solid organ allografts
27. Influence of donor brain death on chronic rejection of renal transplants in rats
28. Hypothermia: A limiting factor in using warm ischemically damaged kidneys
29. Factors influencing early renal function in cadaver kidney transplants: A case-control study
30. Early function as the principal correlate of graft survival: A multivariate analysis of 200 cadaveric renal transplants treated with a protocol incorporating antilymphocyte globulin and cyclosporine
31. The role of the B7 costimulatory pathway in experimental cold ischemia/reperfusion injury
32. Hyperfiltration in remnant nephrons: A potentially adverse response to renal ablation
33. Predictors of the progression of renal disease in the Modification of Diet in Renal Disease Study
34. Baseline characteristics in the modification of diet in renal disease study
35. Ratio of donor kidney weight to recipient bodyweight as an index of graft function
36. No evidence of accelerated loss of kidney function in living kidney donors: Results from a cross-sectional follow-up
37. Comparison of three immunosuppressive regimens in cadaver renal transplantation: Long-term cyclosporine, short-term cyclosporine followed by azathioprine and prednisolone, and azathioprine and prednisolone without cyclosporine
38. Long-term impact of discontinued or reduced calcineurin inhibitor in patients with chronic allograft nephropathy
39. Chronic cyclosporine nephrotoxicity
40. The long-term course of cyclosporine-associated chronic nephropathy
41. Nephrotoxicity of immunosuppressive drugs: Long-term consequences and challenges for the future
42. Tolerance induction in adult mice: Cyclosporine inhibits RS-61443-induced tolerance
43. Cyclosporine-associated chronic nephropathy
44. Target blood pressure for antihypertensive therapy in patients with proteinuric renal disease
45. Effects of blood pressure control on progressive renal disease in blacks and whites
46. Hypertension and progression of renal disease
47. Hypertensive nephrosclerosis as a relevant cause of chronic renal failure
48. Hypertension is associated with hyperlipidemia, coronary heart disease and chronic graft failure in kidney transplant recipients
49. Antihypertensive medication and renal allograft failure: A North American Pediatric Renal Transplant Cooperative Study report
50. Association of chronic kidney graft failure with recipient blood pressure
51. Arterial hypertension and renal allograft survival
52. Relationship between proteinuria and progressive renal disease
53. Effect of dietary protein restriction on nutritional status in the Modification of Diet in Renal Disease Study
54. The prognostic importance of severity and type of post-transplant proteinuria
55. Proteinuria after renal transplantation affects not only graft survival but also patient survival
56. Biochemistry and molecular cell biology of diabetic complications
57. Influence of diabetes mellitus on patient and graft survival in recipients of kidney transplantation
58. Diabetes mellitus after renal transplantation: As deleterious as non-transplant-associated diabetes?
59. Cytomegalovirus infection and graft rejection in renal transplantation
60. Diagnosis and management of posttransplant lymphoproliferative disorder in solid-organ transplant recipients
61. Association between Epstein-Barr virus infection and late acute transplant rejection in long-term transplant patients
62. Transplantation in the patient with hepatitis C
63. BK virus in solid organ transplant recipients: An emerging syndrome
64. Polyomavirus BK nephropathy in a kidney transplant recipient: Critical issues of diagnosis and management
65. BK-related polyomavirus vasculopathy in a renal-transplant recipient
66. Aging and the kidney
67. Aging and the kidney
68. Anatomic and physiologic age changes in the kidney
69. The thickness of the renal parenchyma decreases with age: A CT study of 360 patients
70. Telomere dynamics in cancer progression and prevention: Fundamental differences in human and mouse telomere biology
71. Cellular senescence: Mitotic clock or culture shock?
72. Telomere shortening in kidneys with age
73. Evidence for cellular senescence in tubular epithelium of rodent and human kidneys
74. Telomere shortening in atherosclerosis
75. Telomere attrition of the human abdominal aorta: Relationships with age and atherosclerosis
76. Hypothesis: Pulse pressure and human longevity